LI Yun-Long,YAO Wenqing,COMBS Andrew P.,YUE Eddy W.,MEI Song,ZHU Wenyu,GLENN Joseph,MADUSKUIE Thomas P. Jr.,SPARKS Richard B.,DOUTY Brent,HE Chunhong,MADUSKUI
申请号：
SI201230871
公开号：
SI2751109T1
申请日:
2012.08.31
申请国别(地区):
SI
年份:
2017
代理人:
摘要：
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
